An observational study in Alzheimer Disease, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-01-15.
Sponsored by Assistance Publique - Hôpitaux de Paris · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Alzheimer Disease by Assistance Publique - Hôpitaux de Paris — 9 open to participants now, 9 under way, 1 of them phase 3. Alzheimer Disease · Assistance Publique - Hôpitaux de Paris.
Among the 28 studies in Alzheimer Disease by Assistance Publique - Hôpitaux de Paris, this one is the 14th largest by planned enrollment of the 14 observational ones that give a count, is one of 2 that started in 2025, is one of 14 observational ones, and was the 26th registered.
3,972 studies on the registry are indexed under Alzheimer Disease; 930 are open to participants now.
Browse Alzheimer Disease studies →9 of the 28 studies in Alzheimer Disease by Assistance Publique - Hôpitaux de Paris are open now, in 1 country. Recruiting first, the newest first:
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 50–80
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18–90 · Healthy volunteers
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18–85 · Healthy volunteers
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 50–90
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 55–85
By country, each count listing its studies:
Of the 645 Alzheimer Disease studies recruiting now, 282 (44%) set no upper age limit and 57 (9%) stop at 75 or younger; 34 take children under 18; 288 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 200 across 817 observational studies indexed under Alzheimer Disease.
Median enrollment 91 across the 14 interventional studies, 97 across the 14 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,598 studies on the registry; 1,038 are open to participants now.
4 of the studies in Alzheimer Disease by Assistance Publique - Hôpitaux de Paris that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05977712Assistance Publique - Hôpitaux de ParisCircadian Rhythm and Other Factors in Memory Clinic Patients | 2027-03 |
| NCT06501495Assistance Publique - Hôpitaux de ParisLinks Between Cognitive Deficits During Normal or Pathological Aging and Slow Waves Measured in EEG | 2027-04 |
| NCT06582199Assistance Publique - Hôpitaux de ParisPrecision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD | 2027-09 |
| NCT06068361Assistance Publique - Hôpitaux de ParisDiagnostic Evaluation of Dementia with Lewy Bodies Using a Multimodal Approach | 2027-09 |
Add all 4 to your calendar (.ics) → With an account.
Among the 28 studies in Alzheimer Disease by Assistance Publique - Hôpitaux de Paris, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
In geriatric care, occupational therapists use validated tools to assess abilities and performance, identifying deficiencies and proposing rehabilitation programs. Temporal orientation disorders are common, with studies showing that individuals who make mistakes in identifying time are at higher risk of dementia. Temporal orientation issues typically precede spatial orientation problems in Alzheimer's, especially in hospital settings where environmental cues are lost. Maintaining temporal orientation during hospitalization is crucial. While no effective rehabilitation tool currently exists, a new prototype has been developed to address temporal orientation disorders in Alzheimer's and dementia patients, with plans for further evaluation.
Main Objective Evaluate in real-life conditions the effectiveness of an adapted external aid, such as the Ephéméride 3D tool, in improving temporal orientation rehabilitation for individuals with Alzheimer's disease or related dementias in the mild to moderate stages.
Secondary Objectives
Assess the feasibility of establishing a routine with hospitalized patients. Gather feedback from patients, their families, and healthcare professionals regarding the external aid (usefulness, practicality, and aesthetics) as a prototype.
Evaluate the desire to continue using the tool once patients return home. Count the number of ephémérides deemed appropriate based on positive feedback from patients, families, and healthcare professionals. This figure is valuable for the company that may decide to scale up the product development. It will be calculated from the results of the attached questionnaires.
Method
This is a monocentric pilot observational study with data collection based on the following steps:
Day 5 (D5): Initial MMSE by the patient's physician. Prescription of temporal rehabilitation.
Day 6 (D6): Obtaining consent from the patient and their caregiver. Days 6 to 10 (D6 to D10): Daily assessment of the patient's knowledge of the season, year, month, day of the month (date), and day of the week without external aid (E3D).
Days 11 to 15 (D11 to D15): Daily assessment with external aid (E3D) for the same temporal knowledge.
Day 16 (D16): Interim and partial MMSE by the patient's physician. Days 17 to 21 (D17 to D21): Daily assessment without external aid (E3D). Days 22 to 26 (D22 to D26): Daily assessment with external aid (E3D). Day 27 (D27): Final and complete MMSE by the patient's physician. Days 28 to 30 (D28 to D30): Questionnaires for the patient, their caregiver, and healthcare professionals (including the study referent in the hospital).
20 patients will be included over a 1-year and 30-day period. Descriptive statistical analyses will be conducted to document patient characteristics at admission and the evolution of key parameters over time (D0 to D30). Paired statistical tests (T-tests/Chi-square) will be performed to identify significant changes between visit times. Longitudinal analyses using mixed-effects linear regression models will assess trends over time, accounting for correlations between repeated measures and evaluating differences based on the use of external aids.
Conclusion This observational study primarily aims to describe the feasibility and benefits of using the Ephéméride 3D tool to support temporal orientation rehabilitation in individuals with mild to moderate dementia.
Context and Purpose In geriatric care, especially for individuals with Alzheimer's disease or other dementias, maintaining orientation in time (temporal orientation) is a critical aspect of cognitive function. Occupational therapists, using validated tools, help assess a patient's abilities and performance to identify deficiencies and propose rehabilitation programs tailored to the individual. Temporal orientation disorders, in which individuals struggle with identifying or understanding time (such as the day of the week, month, or year), are common in patients with Alzheimer's disease and related dementias. Research shows that individuals who make errors in temporal orientation-such as misidentifying the day, date, or month-are at a higher risk for developing dementia. Furthermore, temporal orientation issues often precede spatial orientation problems in Alzheimer's patients, meaning they can serve as early indicators of cognitive decline.
In hospital settings, these issues are often worsened due to the loss of personal environmental cues, which can leave patients feeling disoriented and confused. As such, maintaining temporal orientation during hospitalization is essential to reduce distress and support cognitive function. However, despite the clear importance of addressing temporal orientation in dementia care, there is currently no effective tool specifically designed to rehabilitate these deficits. This gap in care has prompted the development of a new tool, the Ephéméride 3D, a prototype external aid aimed at improving temporal orientation in individuals with mild to moderate dementia.
Main Objective The primary goal of this study is to evaluate, in real-life hospital conditions, the effectiveness of the Ephéméride 3D tool in improving temporal orientation rehabilitation for individuals with Alzheimer's disease or related dementias. Specifically, the study focuses on patients in the mild to moderate stages of the disease, where early intervention could be most beneficial.
Secondary Objectives
In addition to evaluating the tool's effectiveness, the study includes several secondary objectives:
Feasibility of Routine Establishment: The study will assess the practicality of integrating the Ephéméride 3D tool into the daily routine of hospitalized patients. This includes evaluating whether the tool can be consistently used throughout a patient's hospitalization period.
Feedback Collection: Patients, their families, and healthcare professionals will provide feedback on the usefulness, practicality, and aesthetic appeal of the Ephéméride 3D tool. This feedback will be critical for determining whether the tool meets the needs of the patients it is designed to assist.
Desire for Continued Use: The study will also investigate whether patients would be willing to continue using the tool once they are discharged from the hospital and return home. This will help gauge the long-term potential of the tool for continuous cognitive support.
Evaluation of Positive Feedback: The study will track the number of Ephémérides deemed appropriate for wider use, based on positive feedback from patients, their families, and healthcare professionals. This feedback will be used to decide whether the product should be scaled for broader development and distribution. A key metric for this evaluation will be derived from the results of questionnaires filled out by patients, their caregivers, and healthcare providers.
Methodology This study is a monocentric pilot observational study, meaning it will be conducted at a single site and will involve direct observations of patients over a defined period. The data collection process will follow a series of structured steps, including assessments of the patients' temporal knowledge at various points during the study.
Study Timeline and Procedures:
Day 5 (D5): The patient's physician will conduct an initial Mini-Mental State Examination (MMSE) to assess cognitive function and prescribe temporal orientation rehabilitation as needed.
Day 6 (D6): Consent will be obtained from both the patient and their caregiver to participate in the study.
Days 6 to 10 (D6 to D10): The patient's knowledge of time (season, year, month, day, and day of the week) will be assessed daily without the Ephéméride 3D tool, to establish a baseline for comparison.
Days 11 to 15 (D11 to D15): The patient's temporal knowledge will be assessed daily with the Ephéméride 3D tool. This period will allow the researchers to observe whether the tool has any positive impact on the patient's ability to maintain temporal orientation.
Day 16 (D16): The patient's physician will conduct an interim MMSE to measure any changes in cognitive function from the baseline.
Days 17 to 21 (D17 to D21): A second round of daily assessments will take place without the Ephéméride 3D tool to observe any reversion in the temporal orientation without external support.
Days 22 to 26 (D22 to D26): Another round of daily assessments with the Ephéméride 3D tool will take place to examine the sustained impact of the tool on temporal orientation.
Day 27 (D27): A final MMSE will be conducted to evaluate any long-term changes in cognitive function resulting from the intervention.
Days 28 to 30 (D28 to D30): Questionnaires will be completed by the patient, their caregiver, and healthcare professionals (including the study referent in the hospital) to gather their opinions on the usefulness and effectiveness of the tool.
Study Population The study will include 20 patients over the course of 1 year and 30 days, providing sufficient data for statistical analysis.
Data Analysis The analysis will involve descriptive statistics to document patient characteristics at admission and track changes over time. Statistical tests such as paired T-tests and Chi-square tests will be used to identify significant changes in temporal orientation across assessment periods. Additionally, longitudinal analyses using mixed-effects linear regression models will assess trends over time, accounting for correlations between repeated measures and evaluating the impact of the Ephéméride 3D tool on temporal orientation.
Expected Outcomes and Conclusion This observational study aims to determine whether the Ephéméride 3D tool can effectively support temporal orientation rehabilitation in individuals with Alzheimer's disease and related dementias. The study will primarily focus on the feasibility of using the tool in a hospital setting and the effectiveness of improving temporal orientation. If the tool proves successful, it could provide a practical solution for addressing temporal orientation deficits, thereby improving the overall quality of life for individuals with cognitive impairments.
The feedback gathered from patients, families, and healthcare providers will be essential in refining the tool and determining whether it is suitable for widespread use. Ultimately, the study will lay the foundation for future development and potential scaling of the Ephéméride 3D tool, with the hope of improving cognitive rehabilitation practices for individuals suffering from Alzheimer's disease and other dementias.
ndividuals hospitalized in a geriatric rehabilitation and follow-up care service.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Unlike other interventions, the E3D tool combines an intuitive, user-friendly interface with real-time temporal cues, offering a personalized experience designed to improve cognitive engagement. This external aid is aimed at fostering independence and improving daily functioning by providing clear and consistent information on time-related aspects, such as season, month, day of the week, and current date.
Evaluation of Temporal Orientation Rehabilitation with the Ephéméride 3D Tool
This outcome measure assesses the effectiveness of the Ephéméride 3D tool in improving temporal orientation for individuals with Alzheimer's disease or related dementias in the mild to moderate stages. It is based on daily assessments of the patient's knowledge of time-related information, including season, year, month, day of the month (date), and day of the week, both with and without the use of the external aid (E3D)
Time frame: 30 days
Plan to share: No — DATAS ARE OWN BY ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, PLEASE CONTACT SPONSOR FOR FURTHER INFORMATION
No publications or documents are linked to this record.
Started Apr 2025 (actual). Primary completion is estimated for Mar 2026, 11 months after the start.
Of 364 non-industry observational studies under Alzheimer Disease, half reached primary completion within 81 months of starting (the median), counting those still running; a quarter within 39 and three quarters within 203. This study's planned 11 months is below that.
Counting every sponsor, half of 405 studies reached it within 67 months; a quarter within 35 and three quarters within 171.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assistance Publique - Hôpitaux de Paris →